Burosumab
Product Specifications
CAS Number
1610833-03-8
Target
Others
Related Pathways
Others
Purity
0.984
Bioactivity
Burosumab (KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS951194-01 1 mg (E-Coli)
Recombinant Cat Cytochrome c oxidase subunit 1 (MT-CO1), partial
Ask
View Details MBS951194-02 1 mg (Yeast)
Recombinant Cat Cytochrome c oxidase subunit 1 (MT-CO1), partial
Ask
View Details 